Mitochondrial dysfunction in schizophrenia: Evidence for compromised brain metabolism and oxidative stress

Molecular Psychiatry

Volumn 9, Issue 7, 2004, Pages 684-697

  Prabakaran, S ^a,b   Swatton, J E ^a,b   Ryan, M M ^a,b   Huffaker, S J ^a,b   Huang, J T J ^a,b   Griffin, J L ^c   Wayland, M ^d   Freeman, T ^d   Dudbridge, F ^d   Lilley, K S ^c   Karp, N A ^c   Hester, S ^c   Tkachev, D ^a,b   Mimmack, M L ^a,b   Yolken, R H ^e   Webster, M J ^f   Torrey, E F ^f   Bahn, S ^a,b,c  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d MRC Rosalind Franklin Ctr Genom R   (United Kingdom)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Functional genomics; Gene ontology; Mitochondria; Oxidative stress; Schizophrenia; Systems based approach

Indexed keywords

ARTICLE; BRAIN METABOLISM; BRAIN TISSUE; CLUSTER ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; SCHIZOPHRENIA;

EID: 3142745187     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001511     Document Type: Article

References (68)

1. Middleton FA, Mirnics K, Pierri JN, Lewis DA, Levitt P. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci 2002; 22: 2718-2729.
2. Hakak Y. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 2001; 98: 4746-4751.
3. Torrey EF, Webster M, Knable M, Johnston N, Yolken RH. The stanley foundation brain collection and neuropathology consortium. Schizophr Res 2000; 44: 151-155.
4. Alban A, David SO, Bjorkesten L, Andersson C, Sloge E, Lewis S et al. A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 2003; 3: 36-44.
5. Griffin JL, Bollard M, Nicholson JK, Bhakoo K. Spectral profiles of cultured neuronal and glial cells derived from HRMAS (1)H NMR spectroscopy. NMR Biomed 2002; 15: 375-384.
6. Ryan MM, Huffaker SJ, Webster MJ, Wayland M, Freeman T, Bahn S. Application and optimization of microarray technologies for human post-mortem brain studies. Biol Psychiatry 2003; 55: 329-336.
7. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U et al. Exploration, normalization and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4: 249-264.
8. Rosner B. Percentage points for a generalized ESD many-outlier procedure. Technometrics 1983; 25: 165-172.
9. Akaike H. Information theory and an extension of the maximum likelihood principle. Second Internatioanl Symposium on Information Theory. Akademiai Kiado, Budapest, 1973 pp 267-281.
10. Ihaka R, Gentleman R. A language for data analysis and graphics. J Comp Graph Stat 1996; 5: 299-314.
11. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25: 25-29.
12. Taylor SW, Fahy E, Zhang B, Glenn GM, Warnock DE, Wiley S et al. Characterization of the human heart mitochondrial proteome. Nat Biotechnol 2003; 21: 281-286.
13. 2 insult. Invest Ophthalmol Vis Sci 2003; 44: 2084-2093.
14. Horie S, Ishii H, Itoh S, Suga T. The noninvolvement of MDH as NAD-oxidoreductase shuttle in rat liver peroxisomes. Biochem Int 1984; 8: 353-359.
15. Fujii J, Ikeda Y. Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein. Redox Rep 2002; 7: 123-130.
16. Koerkamp MG, Rep M, Bussemaker HJ, Hardy GP, Mul A, Piekarska K et al. Dissection of transient oxidative stress response in Saccharomyces cerevisiae by using DNA microarrays. Mol Biol Cell 2002; 13: 2783-2794.
17. Brown GK. Pyruvate dehydrogenase E1 alpha deficiency. J Inherit Metab Dis 1992; 15: 625-633.
18. Hertz L, Dienel GA. Energy metabolism in the brain. Int Rev Neurobiol 2002; 51: 1-102.
19. Michaelis T, Helms G, Frahm J. Metabolic alterations in brain autopsies: proton NMR identification of free glycerol. NMR Biomed 1996; 9: 121-124.
20. Sebastian S, Kenkare UW. Stimulation of brain hexokinase gene expression by recombinant brain insulin-like growth factor in C6 glial cells. Exp Cell Res 1999; 246: 243-247.
21. Guan J, Williams CE, Skinner SJ, Mallard EC, Gluckman PD. The effects of insulin-like growth factor (IGF)-1, IGF-2, and des-IGF-1 on neuronal loss after hypoxic-ischemic brain injury in adult rats: evidence for a role for IGF binding proteins. Endocrinology 1996; 137: 893-898.
22. Roth AD, Leisewitz AV, Jung JE, Cassina P, Barbeito L, Inestrosa NC et al. PPAR gamma activators induce growth arrest and process extension in B12 oligodendrocyte-like cells and terminal differentiation of cultured oligodendrocytes. J Neurosci Res 2003; 72: 425-435.
23. Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003; 362: 798-805.
24. Nagarajan R, Svaren J, Le N, Araki T, Watson M, Milbrandt J. EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron 2001; 30: 355-368.
25. Nagarajan R, Le N, Mahoney H, Araki T, Milbrandt J. Deciphering peripheral nerve myelination by using Schwann cell expression profiling. Proc Natl Acad Sci USA 2002; 99: 8998-9003.
26. Ramsay RR, Gandour RD, van der Leij FR. Molecular enzymology of carnitine transfer and transport. Biochim Biophys Acta 2001; 1546: 21-43.
27. Heininger K. The cerebral glucose-fatty acid cycle: evolutionary roots, regulation, and (patho)physiological importance. Int Rev Neurobiol 2002; 51: 103-158.
28. Sipos I, Tretter L, Adam-Vizi V. Quantitative relationship between inhibition of respiratory complexes and formation of reactive oxygen species in isolated nerve terminals. J Neurochem 2003; 84: 112-118.
29. Carper DA, Sun JK, Iwata T, Zigler Jr JS, Ibaraki N, Lin LR et al. Oxidative stress induces differential gene expression in a human lens epithelial cell line. Invest Ophthalmol Vis Sci 1999; 40: 400-406.
30. Cabiscol E, Piulats E, Echave P, Herrero E, Ross J. Oxidative stress promotes specific protein damage in Saccharomyces cerevisiae. J Biol Chem 2000; 275: 27393-27398.
31. Blass JP. Glucose/mitochondria in neurological conditions. Int Rev Neurobiol 2002; 51: 325-376.
32. Gardner PR, Nguyen DD, White CW. Aconitase is a sensitive and critical target of oxygen poisoning in cultured mammalian cells and in rat lungs. Proc Natl Acad Sci USA 1994; 91: 12248-12252.
33. Saransaari P, Oja SS. Taurine and neural cell damage. Amino Acids 2000; 19: 509-526.
34. Dringen R, Hirrlinger J. Glutathione pathways in the brain. Biol Chem 2003; 384: 505-516.
35. Berggren M, Gallegos A, Gasdaska JR, Gasdaska PY, Warneke J, Powis G. Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia. Anticancer Res 1996; 16: 3459-3466.
36. Das KD, White CW. Redox systems of the cell: possible links and implications. Proc Natl Acad Sci USA 2002; 99: 9617-9618.
37. Kang SW, Chae HZ, Seo MS, Kim K, Baines IC, Rhee SG. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha. J Biol Chem 1998; 273: 6297-6302.
38. Maier CM, Chan PH. Role of superoxide dismutases in oxidative damage and neurodegenerative disorders. Neuroscientist 2002; 8: 323-334.
39. Demchenko IT, Oury TD, Crapo JD, Piantadosi CA. Regulation of the brain's vascular responses to oxygen. Circ Res 2002; 91: 1031-1037.
40. Wheeler MD, Katuna M, Smutney OM et al. Comparison of the effect of adenoviral delivery of three superoxide dismutase genes against hepatic ischemia-reperfusion injury. Hum Gene Ther 2001; 12: 2167-2177.
41. Campagne MV, Thibodeaux H, van Bruggen N, Cairns B, Lowe DG. Increased binding activity at an antioxidant-responsive element in the metallothionein-1 promoter and rapid induction of metallothionein-1 and -2 in response to cerebral ischemia and reperfusion. J Neurosci 2000; 20: 5200-5207.
42. Emerson MR, Samson FE, Pazdernik TL. Effects of hypoxia preconditioning on expression of metallothionein-1,2 and heme oxygenase-1 before and after kainic acid-induced seizures. Cell Mol Biol (Noisy-le-grand) 2000; 46: 619-626.
43. Webster KA. Evolution of the coordinate regulation of glycolytic enzyme genes by hypoxia. J Exp Biol 2003; 206(part 17): 2911-2922.
44. 2- regulated gene expression. FASEB J 2002; 16: 1151-1162.
45. Heidbreder M, Frohlich F, Johren O, Dendorfer A, Qadri F, Dominiak P. Hypoxia rapidly activates HIF-3alpha mRNA expression. FASEB J 2003; 17: 1541-1543.
46. Sharp FR, Bergeron M, Bernaudin M. Hypoxia-inducible factor in brain. Adv Exp Med Biol 2001; 502: 273-291.
47. Harris AL. Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2: 38-47.
48. Sakanaka M, Wen TC, Matsuda S, Masuda S, Morishita E, Nagao M et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA 1998; 95: 4635-4640.
49. Aversa A, Basciani S, Visca P, Arizzi M, Gnessi L, Frajese G et al. Platelet-derived growth factor (PDGF) and PDGF receptors in rat corpus cavernosum: changes in expression after transient in vivo hypoxia. J Endocrinol 2001; 170: 395-402.
50. Cheng B, Mattson MP. PDGFs protect hippocampal neurons against energy deprivation and oxidative injury: evidence for induction of antioxidant pathways. J Neurosci 1995; 15: 7095-7104.
51. Iihara K, Sasahara M, Hashimoto N, Hazama F. Induction of platelet-derived growth factor beta-receptor in focal ischemia of rat brain. J Cereb Blood Flow Metab 1996; 16: 941-949.
52. Sakai Y, Furuichi M, Takahashi M, Mishima M, Iwai S, Shirakawa M et al. A molecular basis for the selective recognition of 2-hydroxy-dATP and 8-oxo-dGTP by human MTH1. J Biol Chem 2002; 277: 8579-8587.
53. Parikh V, Khan MM, Mahadik SP. Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. J Psychiatr Res 2003; 37: 43-51.
54. 1H spectroscopic imaging for evaluating the local metabolic response to focal ischemia in the conscious rat. NMR Biomed 1992; 5: 11-19.
55. Ryan MC, Collins P, Thakore JH. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry 2003; 160: 284-289.
56. Henderson DC, Ettinger ER. Schizophrenia and diabetes,. Int Rev Neurobiol 2002; 51: 481-501.
57. Chambers CB, Lee JM, Troncoso JC, Reich S, Muma NA. Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease. Ann Neurol 1999; 46: 325-332.
58. Barrier L. Evidence that acidosis alters the high-affinity dopamine uptake in rat striatal slices and synaptosomes by different mechanisms partially related to oxidative damage. Neurochem Int 2003; 42: 27-34.
59. Fedorovich SV, Kaler GV, Konev SV. Effect of low pH on glutamate uptake and release in isolated presynaptic endings from rat brain. Neurochem Res 2003; 28: 715-721.
60. Rae C. Is pH a biochemical marker of IQ? Proc R Soc Lond Ser B 1996; 263: 1061-1064.
61. Hakak Y, Walker JR, Li C et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 2001; 98: 4746-4751.
62. Brockmann K. Succinate in dystrophic white matter; a proton magnetic resonance spectroscopy finding characteristics for complex II deficiency. Ann Neurol 2002; 52: 38-46.
63. Jacobson AM, Samson JA, Weinger K, Ryan CM. Diabetes, the brain, and behavior: is there a biological mechanism underlying the association between diabetes and depression? Int Rev Neurobiol 2002; 51: 455-479.
64. Mootha VK. PGC-1 alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34: 267-273.
65. Ben-Shachar D. Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine. J Neurochem 2002; 83: 1241-1251.
66. van Lookeren Campagne M, Thibodeaux H, van Bruggen N, Cairns B, Gerlai R, Palmer JT et al. Evidence for a protective role of metallothionein-1 in focal cerebral ischemia. Proc Natl Acad Sci USA 1999; 96: 12870-12875.
67. Shi Y, Pritchard Jr. KA, Holman P, Rafiee P, Griffith OW, Kalyanaraman B et al. Chronic myocardial hypoxia increases nitric oxide synthase and decreases caveolin-3. Free Radic Biol Med 2000; 29: 695-703.
68. Flavin MP, Yang Y, Ho G. Hypoxia forebrain cholinergic neuron injury: role of glucose, excitatory amino acid receptors and nitric oxide. Neurosci Lett 1993; 164: 5-8.